Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1186/s12879-021-06081-z

http://scihub22266oqcxt.onion/10.1186/s12879-021-06081-z
suck pdf from google scholar
33902480!8072093!33902480
unlimited free pdf from europmc33902480    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33902480&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi

pmid33902480      BMC+Infect+Dis 2021 ; 21 (1): 382
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Epidemiology, clinical characteristics, and treatment outcomes of patients with COVID-19 at Thailand s university-based referral hospital #MMPMID33902480
  • Sirijatuphat R; Suputtamongkol Y; Angkasekwinai N; Horthongkham N; Chayakulkeeree M; Rattanaumpawan P; Koomanachai P; Assanasen S; Rongrungruang Y; Chierakul N; Ratanarat R; Jitmuang A; Wangchinda W; Kantakamalakul W
  • BMC Infect Dis 2021[Apr]; 21 (1): 382 PMID33902480show ga
  • BACKGROUND: The epidemiology and outcomes of COVID-19 patients in Thailand are scarce. METHODS: This retrospective cohort study included adult hospitalized patients who were diagnosed with COVID-19 at Siriraj Hospital during February 2020 to April 2020. RESULTS: The prevalence of COVID-19 was 7.5% (107 COVID-19 patients) among 1409 patients who underwent RT-PCR for SARS-CoV-2 detection at our hospital during the outbreak period. Patients with COVID-19 presented with symptoms in 94.4%. Among the 104 patients who were treated with antiviral medications, 78 (75%) received 2-drug regimen (lopinavir/ritonavir or darunavir/ritonavir plus chloroquine or hydroxychloroquine), and 26 (25%) received a 3-drug regimen with favipiravir added to the 2-drug regimen. Disease progression was observed in 18 patients (16.8%). All patients with COVID-19 were discharged alive. CONCLUSIONS: The prevalence of COVID-19 was 7.5% among patients who underwent RT-PCR testing, and 10% among those having risk factors for COVID-19 acquisition. Combination antiviral therapies for COVID-19 patients were well-tolerated and produced a favorable outcome.
  • |Adult[MESH]
  • |Aged[MESH]
  • |Aged, 80 and over[MESH]
  • |Amides/therapeutic use[MESH]
  • |Antiviral Agents/therapeutic use[MESH]
  • |COVID-19 Drug Treatment[MESH]
  • |COVID-19/*epidemiology[MESH]
  • |Chloroquine/therapeutic use[MESH]
  • |Darunavir/therapeutic use[MESH]
  • |Disease Progression[MESH]
  • |Drug Combinations[MESH]
  • |Female[MESH]
  • |Hospitals[MESH]
  • |Hospitals, University[MESH]
  • |Humans[MESH]
  • |Hydroxychloroquine/therapeutic use[MESH]
  • |Lopinavir/therapeutic use[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Pyrazines/therapeutic use[MESH]
  • |Referral and Consultation[MESH]
  • |Retrospective Studies[MESH]
  • |Ritonavir/therapeutic use[MESH]
  • |Thailand/epidemiology[MESH]
  • |Treatment Outcome[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box